Squarepoint Ops LLC Raises Position in Stevanato Group S.p.A. $STVN

Squarepoint Ops LLC lifted its stake in Stevanato Group S.p.A. (NYSE:STVN) by 131.2% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 193,311 shares of the company’s stock after purchasing an additional 109,702 shares during the period. Squarepoint Ops LLC’s holdings in Stevanato Group were worth $3,493,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of STVN. GW&K Investment Management LLC grew its position in shares of Stevanato Group by 76.2% during the fourth quarter. GW&K Investment Management LLC now owns 2,440 shares of the company’s stock worth $49,000 after buying an additional 1,055 shares in the last quarter. Fifth Third Bancorp lifted its stake in Stevanato Group by 22.6% in the first quarter. Fifth Third Bancorp now owns 4,196 shares of the company’s stock worth $58,000 after acquiring an additional 773 shares during the last quarter. State of Wyoming lifted its stake in Stevanato Group by 39,216.7% in the second quarter. State of Wyoming now owns 2,359 shares of the company’s stock worth $58,000 after acquiring an additional 2,353 shares during the last quarter. Quantbot Technologies LP acquired a new position in Stevanato Group during the 3rd quarter worth approximately $68,000. Finally, Tower Research Capital LLC TRC increased its position in shares of Stevanato Group by 1,268.7% in the 2nd quarter. Tower Research Capital LLC TRC now owns 4,585 shares of the company’s stock valued at $112,000 after purchasing an additional 4,250 shares during the last quarter.

Stevanato Group Price Performance

Stevanato Group stock opened at €20.98 on Friday. The company has a market cap of $6.35 billion, a P/E ratio of 37.47, a price-to-earnings-growth ratio of 1.71 and a beta of 0.75. Stevanato Group S.p.A. has a one year low of €12.89 and a one year high of €28.00. The business has a fifty day moving average of €20.55 and a two-hundred day moving average of €17.84. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.08 and a current ratio of 1.61.

Stevanato Group (NYSE:STVN) last released its quarterly earnings data on Wednesday, August 5th. The company reported €0.14 earnings per share for the quarter, missing the consensus estimate of €0.15 by (€0.01). Stevanato Group had a net margin of 10.99% and a return on equity of 10.43%. The firm had revenue of €302.00 million during the quarter. As a group, analysts predict that Stevanato Group S.p.A. will post 0.69 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities analysts recently commented on STVN shares. TD Cowen raised Stevanato Group to a “strong-buy” rating in a report on Wednesday, June 17th. Weiss Ratings upgraded Stevanato Group from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, August 27th. UBS Group began coverage on Stevanato Group in a research note on Wednesday. They set a “neutral” rating and a $23.00 target price for the company. Finally, Wolfe Research initiated coverage on Stevanato Group in a report on Tuesday, June 2nd. They issued an “outperform” rating and a $21.00 price target for the company. Two analysts have rated the stock with a Strong Buy rating, two have assigned a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, Stevanato Group currently has a consensus rating of “Moderate Buy”.

Insiders Place Their Bets

In related news, CFO Marco Dal Lago sold 4,209 shares of the firm’s stock in a transaction that occurred on Friday, August 7th. The shares were sold at an average price of €20.09, for a total transaction of €84,558.81. Following the sale, the chief financial officer owned 81,144 shares in the company, valued at approximately €1,630,182.96. This trade represents a 4.93% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Karen Flynn sold 1,493 shares of the stock in a transaction on Monday, June 15th. The stock was sold at an average price of €17.09, for a total value of €25,515.37. Following the transaction, the director directly owned 5,757 shares in the company, valued at approximately €98,387.13. This represents a 20.59% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last three months, insiders sold 14,249 shares of company stock valued at $268,346. Insiders own 0.70% of the company’s stock.

Stevanato Group Company Profile

Stevanato Group S.p.A. is an Italy-based developer and manufacturer of drug-containment and drug-delivery solutions for the pharmaceutical, biotechnology and healthcare industries. The company provides products and services designed to support the development, production and administration of injectable medicines.

Its portfolio includes glass vials, cartridges and syringes, as well as other primary packaging components and containment systems. Stevanato Group also offers inspection and packaging equipment, analytical and laboratory services, and drug-delivery technologies such as prefillable syringes and combination-device solutions.